Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
40.35 USD | -0.64% | -6.63% | -33.61% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.61% | 4.93B | |
-1.64% | 90.28B | |
-1.84% | 39.5B | |
-16.20% | 31.71B | |
+60.96% | 26.41B | |
-22.57% | 14.34B | |
-9.66% | 12.89B | |
-11.77% | 11.8B | |
-45.77% | 10.95B | |
+2.62% | 8.85B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Wedbush Raises Apellis Pharmaceuticals' PT to $67 From $60, Keeps Neutral Rating; Says Awaiting Further Clarity on Potential EU Regulatory Path for Syfovre